新聞/Reuters/Gilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboGilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% Placebo閱讀全文無限制訪問Reuters以及TradingView所有其他新聞來源的文章。繼續閱讀
